CIBC Bancorp USA’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$115M Sell
790,745
-126,478
-14% -$17.5M 0.14% 141
2026
Q2
$118M Sell
917,223
-129,892
-12% -$15.2M 0.14% 148
2026
Q1
$126M Buy
+1,047,115
New +$121M 0.17% 133
2025
Q3
$29M Buy
+345,081
New +$28.4M 0.16% 99

Other funds holding MRK

CIBC Bancorp USA's MRK Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Merck (MRK) stake by 14% in Q3 2026, selling an estimated $17.5M and leaving 790,745 shares worth $115M. The position accounts for 0.14% of the portfolio, ranked #141.

CIBC Bancorp USA first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. The position peaked at $126M in Q1 2026. 3,953 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • CIBC Bancorp USA held 790,745 shares of Merck worth $115M as of Q3 2026.
  • CIBC Bancorp USA sold 126,478 Merck shares in Q3 2026, an estimated $17.5M.
  • Merck made up 0.14% of CIBC Bancorp USA's portfolio in Q3 2026, its #141 holding.
  • CIBC Bancorp USA first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Merck position peaked at $126M in Q1 2026.
  • 3,953 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.